Form 4: Director Sells EVLV Shares Under 10b5-1 Plan

Evolv Technologies Director Michael Ellenbogen sold 80,745 Class A Common Stock shares for $6.20 each after exercising options.

Summary

• Director Michael Ellenbogen exercised options to acquire 80,745 shares of Class A Common Stock at $0.24 per share.
• Simultaneously, he sold 80,745 shares of Class A Common Stock at a weighted average price of $6.20 per share, with prices ranging from $6.13 to $6.37.
• The sales were executed under a pre-arranged Rule 10b5-1 trading plan established on June 12, 2025.
• Following these transactions, Ellenbogen directly owns 2,083,961 Class A Common Stock shares and indirectly owns 151,135 shares through the Family Horizon Trust.
• He also directly holds 1,300,739 stock options, which have an expiration date of September 13, 2027.

Sentiment

Score: 5

Explanation: The transaction is neutral in terms of company sentiment. It represents a director exercising options and selling shares for personal liquidity, which is a common occurrence, especially when executed under a pre-planned 10b5-1 trading plan. It does not signal strong positive or negative sentiment about the company's future prospects.

Positives

• The transaction demonstrates the exercise of options at a significantly lower price ($0.24) compared to the sale price ($6.20), indicating a profitable event for the director.
• The sale was conducted under a Rule 10b5-1 plan, suggesting a pre-planned liquidity event rather than a reaction to recent negative company news.

Negatives

• A director selling shares, even under a 10b5-1 plan, can sometimes be perceived negatively by the market as it reduces direct insider ownership.

Future Outlook

NA

Industry Context

This Form 4 filing reports an insider transaction, which is a routine disclosure for publicly traded companies. It does not provide specific industry context or trends, but rather details a director's personal stock activity within Evolv Technologies Holdings, Inc.

Stakeholder Impact

• Shareholders may observe a slight reduction in direct insider ownership, though the overall impact is likely minimal given the pre-planned nature of the sale and the director's remaining holdings.

Key Dates

Recommendation

The filing details a routine insider transaction (option exercise and sale) executed under a pre-planned 10b5-1 trading plan. This type of transaction typically does not provide new fundamental information about the company's operational performance or future outlook that would warrant a change in investment recommendation. The director retains significant holdings, suggesting continued alignment with shareholder interests. Therefore, a 'hold' recommendation is appropriate as this filing alone does not present a compelling reason to buy or sell.

Keywords

Evolv Technologies, EVLV, Michael Ellenbogen, Insider Trading, Form 4, Stock Option Exercise, Share Sale, 10b5-1 Plan, Director Transaction